NCT01224613View on ClinicalTrials.gov

Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

Intanza

0.1 mL of Intanza intradermally at visit # 1

BIOLOGICAL

Intanza

0.1 mL of Intanza intradermally at visit #1

Trial Locations (2)

B3K 6R8

Canadian Center for Vaccinology, Halifax

M5K 1X5

Mount Sinai Hospital, Toronto

Sponsors
All Listed Sponsors
collaborator

IWK Health Centre

OTHER

collaborator

MCM Vaccines B.V.

INDUSTRY

collaborator

Mount Sinai Hospital, Canada

OTHER

lead

Dalhousie University

OTHER